{"product_id":"tongue-retaining-device-profitability","title":"How Increase Tongue Retaining Device Sales Profitability?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eTongue Retaining Device Sales Strategies to Increase Profitability\u003c\/h2\u003e\n\u003cp\u003eTongue Retaining Device Sales starts with exceptional financial health, achieving a \u003cstrong\u003e522% EBITDA margin\u003c\/strong\u003e in Year 1 on $70 million in revenue, and scaling to 624% by Year 5 This high profitability is driven by strong gross margins, but you must actively manage scaling costs like R\u0026amp;D and sales commissions This guide outlines seven strategies to push EBITDA margins past 60% and ensure that your high-dollar contribution products, like the premium device (priced at $495), dominate the sales mix You broke even in month one, but sustaining this requires optimizing Cost of Goods Sold (COGS) and controlling the 135% variable Selling, General, and Administrative (SG\u0026amp;A) costs\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Strategies to Increase Profitability of \u003c\/span\u003eTongue Retaining Device Sales\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eStrategy\u003c\/th\u003e\n\u003cth\u003eProfit Lever\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eExpected Impact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003ePrioritize High-Contribution Devices\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eMarket the $495 Premium device more heavily than the $249 Basic device to lift overall profit per sale.\u003c\/td\u003e\n\u003ctd\u003eGenerates nearly double the dollar profit per unit sold compared to the Basic model.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eMaximize Accessory Attachment Rate\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003ePush sales of the $45 Cleaning Kit and $25 Liners immediately after the primary device purchase.\u003c\/td\u003e\n\u003ctd\u003eCreates predictable, high-frequency revenue streams, especially from Liners with 760% gross margins.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eReduce Material Input Costs\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eNegotiate better pricing for key components like the $2200 Titanium Screws and $1200 Polymer.\u003c\/td\u003e\n\u003ctd\u003eAims to shave 5-10% off the $116 million in annual direct Cost of Goods Sold (COGS).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eScale Fixed Production Overhead\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eEnsure fixed overhead costs, like Factory Insurance (0.5%) and Regulatory Audit Fees (0.4%), grow slower than unit volume.\u003c\/td\u003e\n\u003ctd\u003eBoosts gross margin percentage by managing the 149% indirect COGS percentage more efficiently.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eOptimize Variable SG\u0026amp;A Spend\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eReview the 80% Digital Marketing budget and 30% Sales Commissions; shift volume toward direct clinical channels.\u003c\/td\u003e\n\u003ctd\u003eReduces the overall 135% variable Selling, General, and Administrative (SG\u0026amp;A) burden without stalling growth.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eControl Non-Scaling Fixed Costs\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eScrutinize the $28,200 monthly fixed operating expenses, especially the $5,000 Legal and Patent Maintenance.\u003c\/td\u003e\n\u003ctd\u003eEnsures fixed spending is defintely tied to strategic growth initiatives rather than legacy overhead.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eImplement Strategic Price Increases\u003c\/td\u003e\n\u003ctd\u003ePricing\u003c\/td\u003e\n\u003ctd\u003eAnalyze if the medical device positioning supports immediate, targeted 3-5% price hikes now, rather than waiting for 2029.\u003c\/td\u003e\n\u003ctd\u003eAllows for immediate expansion of the current 52% EBITDA margin.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the true gross margin percentage for each device category?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe \u003cstrong\u003ePremium\u003c\/strong\u003e device generates the highest absolute dollar contribution per sale, which is what truly drives bottom-line growth for Tongue Retaining Device Sales, even if the Travel model shows a slightly better percentage margin; honestly, you need to look past the percentage math when assessing \u003ca href=\"\/blogs\/operating-costs\/tongue-retaining-device\"\u003eWhat Are Operating Costs For Tongue Retaining Device Sales?\u003c\/a\u003e. We need to confirm the direct Cost of Goods Sold (COGS) for each tier to see the real picture, not just the theoretical gross margin percentage.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDollar Contribution Wins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePremium device yields \u003cstrong\u003e$5,300\u003c\/strong\u003e gross profit per unit.\u003c\/li\u003e\n\u003cli\u003eBasic device contributes \u003cstrong\u003e$2,450\u003c\/strong\u003e in gross profit dollars.\u003c\/li\u003e\n\u003cli\u003eTravel device profit is \u003cstrong\u003e$3,280\u003c\/strong\u003e per unit sold.\u003c\/li\u003e\n\u003cli\u003eFocus on the absolute dollar impact, not just the percentage spread.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCOGS vs. Price Reality\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePremium COGS is \u003cstrong\u003e$2,500\u003c\/strong\u003e against a \u003cstrong\u003e$7,800\u003c\/strong\u003e price tag.\u003c\/li\u003e\n\u003cli\u003eBasic device COGS is \u003cstrong\u003e$1,200\u003c\/strong\u003e on a \u003cstrong\u003e$3,650\u003c\/strong\u003e sale price.\u003c\/li\u003e\n\u003cli\u003eTravel device COGS sits at \u003cstrong\u003e$1,500\u003c\/strong\u003e, giving it a \u003cstrong\u003e68.6%\u003c\/strong\u003e margin.\u003c\/li\u003e\n\u003cli\u003eIf manufacturing lead times stretch past 14 days, supply chain costs defintely rise.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow can we shift the sales mix to maximize dollar contribution per transaction?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eTo maximize dollar contribution per transaction for your Tongue Retaining Device Sales operation, you need to aggressively shift volume toward the Premium model, as detailed in this guide on \u003ca href=\"\/blogs\/how-to-open\/tongue-retaining-device\"\u003eHow To Launch Tongue Retaining Device Sales Business?\u003c\/a\u003e. The Premium device yields a direct profit of \u003cstrong\u003e$417\u003c\/strong\u003e, which dwarfs the \u003cstrong\u003e$21250\u003c\/strong\u003e profit from the Basic device, making volume allocation straightforward.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDollar Contribution Priority\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePremium sale price is \u003cstrong\u003e$495\u003c\/strong\u003e; Basic is \u003cstrong\u003e$249\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003ePremium yields \u003cstrong\u003e$417\u003c\/strong\u003e direct profit per unit.\u003c\/li\u003e\n\u003cli\u003eBasic yields \u003cstrong\u003e$21250\u003c\/strong\u003e direct profit per unit.\u003c\/li\u003e\n\u003cli\u003eGrowth defintely requires focusing on unit volume of the Premium tier.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhy Absolute Dollars Win\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAbsolute dollar profit drives cash flow faster than margin percentage.\u003c\/li\u003e\n\u003cli\u003eThe prompt suggests the Premium device has a slightly lower percentage margin.\u003c\/li\u003e\n\u003cli\u003eStill, every Premium sale contributes \u003cstrong\u003e$417\u003c\/strong\u003e toward fixed costs.\u003c\/li\u003e\n\u003cli\u003eThis maximizes the dollar amount covering overhead per transaction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre the 149% indirect COGS categories optimized for future volume?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour \u003cstrong\u003e149% indirect COGS\u003c\/strong\u003e category needs immediate review, specifically the fixed production overheads, because these costs could quickly overwhelm your \u003cstrong\u003e686% gross margin\u003c\/strong\u003e if they don't scale well. For Tongue Retaining Device Sales, you've got to confirm that Quality Control Testing and Supervisory Indirect Labor costs remain variable or decrease as production volume rises.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Overhead Exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIndirect COGS sits at \u003cstrong\u003e149%\u003c\/strong\u003e of revenue, which is unsustainable.\u003c\/li\u003e\n\u003cli\u003eQuality Control Testing is a fixed cost consuming \u003cstrong\u003e12%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eSupervisory Indirect Labor also consumes a fixed \u003cstrong\u003e12%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eThese two line items alone account for \u003cstrong\u003e24%\u003c\/strong\u003e of revenue locked in place.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eScaling Margin Protection\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eModel how QC scales if volume doubles next quarter.\u003c\/li\u003e\n\u003cli\u003eIf supervisory staff doesn't increase, this percentage drops fast.\u003c\/li\u003e\n\u003cli\u003eYou need to check \u003ca href=\"\/blogs\/operating-costs\/tongue-retaining-device\"\u003eWhat Are Operating Costs For Tongue Retaining Device Sales?\u003c\/a\u003e right now.\u003c\/li\u003e\n\u003cli\u003eFocus on automating testing to convert QC from fixed to variable.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhere is the point of diminishing returns for the 80% Digital Marketing spend?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe point of diminishing returns for the \u003cstrong\u003e80%\u003c\/strong\u003e Digital Marketing spend is reached when the marginal cost of acquiring a new customer via digital ads exceeds the projected net present value of that customer, forcing a strategic reallocation toward fixed-cost investments like clinical sales personnel.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDigital Spend Saturation Point\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDigital CAC (Customer Acquisition Cost) growth often becomes non-linear after initial efficient spend tiers.\u003c\/li\u003e\n\u003cli\u003eWhen digital spend hits \u003cstrong\u003e80%\u003c\/strong\u003e of the total budget, variable costs quickly erode contribution margin.\u003c\/li\u003e\n\u003cli\u003eScaling further risks buying lower-quality leads who are less likely to adhere to treatment.\u003c\/li\u003e\n\u003cli\u003eYou must compare the cost of one more digital dollar against the cost of one more clinical sales hire.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePivot to High-Value Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShift focus to B2B channels like dental and sleep clinics for better volume.\u003c\/li\u003e\n\u003cli\u003eHiring Sales FTEs (Full-Time Equivalents) requires upfront fixed cost but secures better LTV.\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D investment drives product improvements that reduce future support costs.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes \u003cstrong\u003e14+\u003c\/strong\u003e days, churn risk rises, making clinical referrals more valuable. See \u003ca href=\"\/blogs\/operating-costs\/tongue-retaining-device\"\u003eWhat Are Operating Costs For Tongue Retaining Device Sales?\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003ePrioritizing the sales mix toward the high-dollar contribution Premium device ($495) over the Basic device is essential for maximizing transaction profitability.\u003c\/li\u003e\n\n\u003cli\u003eAchieving 60%+ EBITDA margins requires rigorous optimization of both direct material costs and the substantial 149% indirect COGS structure.\u003c\/li\u003e\n\n\u003cli\u003eLeveraging high-margin accessory attachment rates, like cleaning kits, creates predictable, high-frequency revenue streams that enhance long-term scaling efficiency.\u003c\/li\u003e\n\n\u003cli\u003eRe-evaluating the 80% digital marketing spend is critical to ensure variable SG\u0026amp;A costs shrink proportionally as the business shifts focus toward higher-value clinical channels.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 1\n: \u003cspan style=\"color: #126CFF;\"\u003ePrioritize High-Contribution Devices\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFocus on Premium Profit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDirect your customer acquisition budget toward the \u003cstrong\u003e$495\u003c\/strong\u003e Premium device. This unit delivers almost \u003cstrong\u003etwice the dollar profit\u003c\/strong\u003e of the \u003cstrong\u003e$249\u003c\/strong\u003e Basic model. Prioritizing higher-value sales immediately lifts your blended margin profile. That's just smart scaling.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMaterial Input Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDevice production hinges on sourcing key parts like the \u003cstrong\u003e$2,200\u003c\/strong\u003e Titanium Screws and \u003cstrong\u003e$1,200\u003c\/strong\u003e Polymer. These costs feed into the \u003cstrong\u003e$116 million\u003c\/strong\u003e annual direct COGS figure. You need supplier quotes now to model the impact of a \u003cstrong\u003e5-10%\u003c\/strong\u003e reduction.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTaming Sales Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eVariable SG\u0026amp;A runs high at \u003cstrong\u003e135%\u003c\/strong\u003e, driven by \u003cstrong\u003e80%\u003c\/strong\u003e digital marketing spend. If you push the Premium device through direct clinical channels instead of heavy digital ads, you can lower acquisition costs. That shift affects the \u003cstrong\u003e30%\u003c\/strong\u003e sales commission structure too. Defintely look at that trade-off.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Quality Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSelling the \u003cstrong\u003e$249\u003c\/strong\u003e Basic unit might seem easy, but it pressures your \u003cstrong\u003e52%\u003c\/strong\u003e EBITDA margin goal. Every Premium sale at \u003cstrong\u003e$495\u003c\/strong\u003e pulls that blended margin up significantly. Don't chase low-quality volume just because it's easier to sell today.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 2\n: \u003cspan style=\"color: #126CFF;\"\u003eMaximize Accessory Attachment Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBoost Aftermarket Profit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou need to push the $45 Cleaning Kit and $25 Liners hard right after the main sale. These add-ons create reliable, frequent income streams because they are consumables. The Liners, specifically, carry an incredible \u003cstrong\u003e760%\u003c\/strong\u003e gross margin, making them pure profit drivers. That's the fastest way to improve lifetime customer value.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAccessory Cost Structure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFocus on the gross profit potential of these consumables. The $25 Liners offer \u003cstrong\u003e760%\u003c\/strong\u003e margin, meaning for every dollar of cost, you generate $7.60 in profit before operating expenses. Estimate required inventory by projecting attachment rates onto the \u003cstrong\u003eannual units produced\u003c\/strong\u003e of the main device. You need to know the unit cost of goods sold (COGS) for the $45 Kit to price it correctly.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePrice Liners at $25.\u003c\/li\u003e\n\u003cli\u003eKit sells for $45.\u003c\/li\u003e\n\u003cli\u003eTrack attachment rate %.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAttachment Tactics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo lift attachment, integrate the offer directly into the checkout flow, perhaps bundling the Kit with the device for a slight discount. Avoid making the add-on feel like an afterthought; present it as essential maintenance. If onboarding takes 14+ days, churn risk rises if customers don't have the cleaning supplies ready. That's a defintely missed opportunity.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBundle accessories at checkout.\u003c\/li\u003e\n\u003cli\u003eTrain sales on maintenance necessity.\u003c\/li\u003e\n\u003cli\u003eTest mandatory initial kit inclusion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProfit Lever\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eConsumables with margins this high directly impact your EBITDA margin, which is currently \u003cstrong\u003e52%\u003c\/strong\u003e. Every attachment sale acts like a small, immediate margin boost, offsetting pressure from fixed costs like the $28,200 monthly operating expenses. This revenue stream is far more stable than waiting for a 2029 price hike.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 3\n: \u003cspan style=\"color: #126CFF;\"\u003eReduce Material Input Costs\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTarget Material Input Costs Now\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must immediately target component sourcing to protect gross margin. Negotiating a \u003cstrong\u003e5-10%\u003c\/strong\u003e reduction on key inputs like the \u003cstrong\u003e$2,200 screws\u003c\/strong\u003e and \u003cstrong\u003e$1,200 polymer\u003c\/strong\u003e directly impacts your \u003cstrong\u003e$116 million\u003c\/strong\u003e direct COGS base. This is low-hanging fruit for profitability improvement.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUnderstanding Material Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDirect Cost of Goods Sold (COGS) covers raw materials needed to build the oral appliances. You need the current unit cost breakdown for the \u003cstrong\u003e$2,200 Adjustable Titanium Screws\u003c\/strong\u003e and the \u003cstrong\u003e$1,200 Medical Grade Polymer\u003c\/strong\u003e. These two items are significant drivers within the total \u003cstrong\u003e$116 million\u003c\/strong\u003e annual direct COGS.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eScrews: $2,200 per unit.\u003c\/li\u003e\n\u003cli\u003ePolymer: $1,200 per unit.\u003c\/li\u003e\n\u003cli\u003eTotal Annual Direct COGS: $116M.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eNegotiating Component Pricing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFocus supplier negotiations on volume commitments for these specialized parts. If you achieve even a \u003cstrong\u003e7%\u003c\/strong\u003e cost reduction, that's nearly \u003cstrong\u003e$8.1 million\u003c\/strong\u003e saved annually off the \u003cstrong\u003e$116M\u003c\/strong\u003e COGS. Don't let supplier inertia stop you from pushing for better terms, especially given the high unit prices.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTarget 5% to 10% reduction.\u003c\/li\u003e\n\u003cli\u003eCalculate savings based on volume.\u003c\/li\u003e\n\u003cli\u003eAvoid quality compromises for price cuts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eActionable Sourcing Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eWhen talking to suppliers, frame the discussion around future volume projections rather than just current spend. If onboarding takes 14+ days, churn risk rises due to delayed cost savings implementation. You defintely need firm commitments by Q3 to realize full impact next fiscal year.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 4\n: \u003cspan style=\"color: #126CFF;\"\u003eScale Fixed Production Overhead\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOverhead Growth Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must decouple fixed overhead growth from unit sales volume to fix the \u003cstrong\u003e149% indirect COGS\u003c\/strong\u003e. Keep costs like \u003cstrong\u003eFactory Insurance (5%)\u003c\/strong\u003e and \u003cstrong\u003eRegulatory Audit Fees (4%)\u003c\/strong\u003e from scaling too fast. This forces the gross margin percentage higher as you produce more units.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInsurance Cost Input\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eFactory Insurance (5% of indirect COGS)\u003c\/strong\u003e covers physical assets and liability at your production site. Estimate this based on the insured value of the facility and equipment, quoted annually. This is a fixed cost that shouldn't rise unless you expand the physical footprint significantly, regardless of unit count.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFacility asset valuation.\u003c\/li\u003e\n\u003cli\u003eAnnual premium quotes.\u003c\/li\u003e\n\u003cli\u003eFixed monthly expense.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAudit Fee Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eRegulatory Audit Fees (4%)\u003c\/strong\u003e are mandatory for medical devices but can be optimized. Bundle compliance checks when possible or negotiate fixed annual rates instead of per-incident billing. Avoid rushing audits, which forces premium service charges. It's defintely worth the effort.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate fixed annual contracts.\u003c\/li\u003e\n\u003cli\u003eBundle required compliance checks.\u003c\/li\u003e\n\u003cli\u003eAvoid rush fees entirely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Lever\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you successfully grow unit volume while holding these fixed overhead percentages steady, the overhead cost per unit drops sharply. This directly improves the gross margin percentage, which is essential when fighting a bloated \u003cstrong\u003e149% indirect COGS\u003c\/strong\u003e figure.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 5\n: \u003cspan style=\"color: #126CFF;\"\u003eOptimize Variable SG\u0026amp;A Spend\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Variable SG\u0026amp;A Burden\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour \u003cstrong\u003e135%\u003c\/strong\u003e variable SG\u0026amp;A, driven by \u003cstrong\u003e80%\u003c\/strong\u003e digital marketing and \u003cstrong\u003e30%\u003c\/strong\u003e commissions, is unsustainable for growth. You must test shifting volume to direct clinical channels immediately. This channel shift is the fastest way to lower customer acquisition costs (CAC) and improve margin quality, even if initial volume is slower.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVariable Spend Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThese costs cover getting the device into the patient's hands. Digital marketing is the \u003cstrong\u003e80%\u003c\/strong\u003e spend on ads and content driving traffic. Sales commissions are the \u003cstrong\u003e30%\u003c\/strong\u003e paid out for closing deals, likely through referral partners or internal reps. Together, they eat up \u003cstrong\u003e135%\u003c\/strong\u003e of your baseline, meaning you lose money on every initial sale before fixed costs hit.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eModel commission savings vs. clinical outreach cost.\u003c\/li\u003e\n\u003cli\u003eTarget CPAP-intolerant patients first.\u003c\/li\u003e\n\u003cli\u003eMeasure growth retention, not just initial volume.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eShift to Clinical Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDirect clinical channels bypass expensive digital funnels and high sales commissions. If a physician prescribes the device, the cost structure changes completely. You need to model the cost of a clinical partnership versus the \u003cstrong\u003e80%\u003c\/strong\u003e digital spend. It's about trading high-cost acquisition for higher-trust, lower-cost adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eImpact on Profitability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf clinical adoption replaces just half of your digital volume, you cut \u003cstrong\u003e40%\u003c\/strong\u003e from the \u003cstrong\u003e80%\u003c\/strong\u003e marketing spend and likely reduce the \u003cstrong\u003e30%\u003c\/strong\u003e commission structure substantially. This move immediately improves the overall \u003cstrong\u003e135%\u003c\/strong\u003e variable burden, freeing up cash needed to scale production or improve the \u003cstrong\u003e52%\u003c\/strong\u003e EBITDA margin target.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 6\n: \u003cspan style=\"color: #126CFF;\"\u003eControl Non-Scaling Fixed Costs\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePin Down Fixed Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour \u003cstrong\u003e$28,200\u003c\/strong\u003e monthly fixed operating expenses need immediate review to ensure they support scaling, not just historical inertia. Focus hard on the \u003cstrong\u003e$5,000\u003c\/strong\u003e Legal and Patent Maintenance and the \u003cstrong\u003e$4,000\u003c\/strong\u003e R\u0026amp;D Lab Maintenance line items. If these aren't driving immediate product updates or compliance for current sales channels, they are drag.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eScrutinize Specific Fixed Line Items\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe \u003cstrong\u003e$5,000\u003c\/strong\u003e Legal and Patent Maintenance covers protecting your intellectual property, like the tongue-retaining mechanism design. The \u003cstrong\u003e$4,000\u003c\/strong\u003e R\u0026amp;D Lab Maintenance covers upkeep for equipment needed to test new polymer blends or device iterations. These costs total \u003cstrong\u003e$9,000\u003c\/strong\u003e monthly, or \u003cstrong\u003e32%\u003c\/strong\u003e of total fixed overhead, and must be defintely tied to growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLegal spend: \u003cstrong\u003e$5,000\u003c\/strong\u003e monthly\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D Lab upkeep: \u003cstrong\u003e$4,000\u003c\/strong\u003e monthly\u003c\/li\u003e\n\u003cli\u003eTotal review amount: \u003cstrong\u003e$9,000\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eChallenge Legacy Fixed Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDon't let old agreements dictate your burn rate. For legal costs, check if patent annuities can be deferred or if ongoing maintenance is required for patents not yet generating revenue. R\u0026amp;D lab costs should be tied to a clear product roadmap milestone; if the roadmap is paused, reduce the lab footprint or negotiate equipment leases down.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTie R\u0026amp;D to active product launches\u003c\/li\u003e\n\u003cli\u003eAudit all recurring patent fees\u003c\/li\u003e\n\u003cli\u003eSeek lower maintenance contracts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLink Spend to Unit Economics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEvery dollar in fixed overhead must be justified against the contribution margin of your devices. If the \u003cstrong\u003e$495\u003c\/strong\u003e Premium device is your focus, ensure the R\u0026amp;D spend is improving that specific unit or enabling a \u003cstrong\u003e760%\u003c\/strong\u003e margin accessory sale. Otherwise, cut it now.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 7\n: \u003cspan style=\"color: #126CFF;\"\u003eImplement Strategic Price Increases\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePrice Hike Timing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou should test \u003cstrong\u003e3-5% price increases\u003c\/strong\u003e now because your premium positioning justifies moving faster than the planned 2029 adjustments. Waiting for the 2029 bump, like the Basic device moving from \u003cstrong\u003e$249 to $255\u003c\/strong\u003e, leaves immediate margin expansion on the table for your \u003cstrong\u003e52% EBITDA margin\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInput Cost Context\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCurrent pricing reflects high input costs, which supports a value-based price increase now. The Basic device sells for $249, but key components like the \u003cstrong\u003e$1200 Medical Grade Polymer\u003c\/strong\u003e suggest high underlying cost pressure. You need to track the total direct COGS, currently \u003cstrong\u003e$116 million annually\u003c\/strong\u003e, against unit volume to confirm price elasticity.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBasic Device Price: $249\u003c\/li\u003e\n\u003cli\u003ePremium Device Price: $495\u003c\/li\u003e\n\u003cli\u003eAnnual Direct COGS: $116 million\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour \u003cstrong\u003e52% EBITDA margin\u003c\/strong\u003e is strong, but price hikes must be targeted to maintain patient acceptance in the medical space. Focus initial increases on the \u003cstrong\u003e$495 Premium device\u003c\/strong\u003e, since it generates nearly double the dollar profit versus the $249 Basic model. This immediately improves your revenue quality.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBoost sales of the $495 Premium device.\u003c\/li\u003e\n\u003cli\u003eTest 3-5% hikes on high-value customers first.\u003c\/li\u003e\n\u003cli\u003eEnsure compliance documentation supports the higher perceived value.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePrice Hike Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you delay the 3-5% hike until 2029, you miss out on immediate cash flow to offset rising fixed costs like the \u003cstrong\u003e$5,000 monthly Legal and Patent Maintenance\u003c\/strong\u003e. Your high-quality positioning is the shield; use it now to expand margins defintely.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304456003827,"sku":"tongue-retaining-device-profitability","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/tongue-retaining-device-profitability.webp?v=1782694019","url":"https:\/\/financialmodelslab.com\/products\/tongue-retaining-device-profitability","provider":"Financial Models Lab","version":"1.0","type":"link"}